DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ambavane A, Yang S, Atkins MB. et al.
Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma.
Immunotherapy 2020;
12 (01) 37-51
We do not assume any responsibility for the contents of the web pages of other providers.